Quince (QNCX) Explodes 59% in 7 Days — Is Quince Therapeutics Headed for a Major Breakout?
Quince Therapeutics Inc. (NASDAQ:QNCX) is a clinical-stage biopharmaceutical company built on a foundation of scientific reinvention and strategic…
Mobile-health Network Solutions (MNDR) Skyrockets 33.69% After Announcing Massive Malaysia AI Data Center Expansion
Mobile-health Network Solutions (NASDAQ:MNDR) is an emerging player in the global digital health and AI-enabled healthcare ecosystem, established…
CEL-SCI (CVM) Surges as Investors Revisit 10-Year Phase 3 Data and Multikine’s 14.1% OS Benefit
Cel-Sci Corporation (NYSE:CVM) is a long-established biotechnology company built on a singular mission: to transform the treatment of…
Trevi Therapeutics (TRVI) Narrows Q3 Loss to $11.8M as Haduvio Advances Toward Major Milestone
Trevi Therapeutics, Inc. (NASDAQ:TRVI) is a clinical-stage biopharmaceutical company founded with a mission to develop transformative therapies for…
Silexion Therapeutics (SLXN) Targets KRAS Mutation Market Worth $5.8B—Here’s Why Investors Are Watching Closely
Silexion Therapeutics Corp. (NASDAQ:SLXN) is a clinical-stage, oncology-focused biotechnology company built on a clear mission: to develop transformative,…
Quantum BioPharma (QBIO) Emerges as Precision Medicine Breakthrough Leader
Quantum BioPharma (NASDAQ:QBIO) is an emerging biotechnology company built on a foundation of precision medicine, advanced molecular engineering,…
NeOnc Technologies (NTHI) Stuns Wall Street With Breakthrough 21% Response Rate in Brain Cancer Trial
NeOnc Technologies Holdings Inc. (OTC:NTHI) is a multi–Phase 2 clinical-stage biopharmaceutical company founded to solve one of the…
Annovis Bio (ANVS) Director Buys 34,000 Shares—Is This the Biggest Insider Bullish Signal of 2025?
Annovis Bio, Inc. (NASDAQ:ANVS) is a clinical-stage biotechnology company founded with a singular mission: to develop transformative therapies…
Surrozen (SRZN) Surges as Wnt Regeneration Pipeline Targets Wet AMD and DME
Surrozen Inc. (NASDAQ:SRZN) is a biotechnology company founded on the pioneering scientific vision that precise modulation of the…
Kazia Therapeutics (KZIA) Faces Nasdaq Hearing After Missing Compliance
Kazia Therapeutics Limited (NASDAQ:KZIA) is a clinical-stage oncology biotechnology company built on more than two decades of research…
CalciMedica (CALC) Advances Phase 2 Trial for Acute Kidney Injury
CalciMedica Inc. (NASDAQ:CALC) is a clinical-stage biopharmaceutical company built on over a decade of pioneering research in calcium…
Cardio Diagnostics (CDIO) Surges as 15 New Provider Partnerships Accelerate National Adoption
Cardio Diagnostics (NASDAQ:CDIO) is a pioneering artificial intelligence-driven precision cardiovascular medicine company built on years of scientific discovery,…
Inspire Medical Systems (INSP) Soars 28% After CMS Approves Massive $10,000 Reimbursement Increase
Inspire Medical Systems (NYSE:INSP) is a pioneering medical technology company built on the mission of transforming the treatment…
Wize Pharma (WIZP) Gains Momentum as LO2A Shows Proven Success With 1.53M Packages Sold
Wize Pharma (OTC:WIZP) is a specialty pharmaceutical company focused on the development and commercialization of targeted ophthalmic treatments,…
Turn Therapeutics (TTRX) Named Top Innovator in Atopic Dermatitis With GX-03 Breakthrough
Turn Therapeutics Inc. (NASDAQ:TTRX) is a clinical-stage biotechnology company built on a foundation of innovation in dermatology, advanced…
Herbalife (HLF) Surges After Q3 2025 Beat
Herbalife Ltd. (NYSE:HLF) is a global health and wellness company with more than four decades of history built…
Mobile-health Network Solutions (MNDR) Signs $120M MOU to Acquire Two Malaysian AI Data Centers
Mobile-health Network Solutions (NASDAQ:MNDR) is an emerging AI-driven HealthTech company built on a foundation of digital innovation, mobile…
Nano-X Imaging (NNOX) Gains Momentum as 3DR Labs Brings Its AI to 1,800 Providers
Nano-X Imaging Ltd. (NASDAQ:NNOX) is a medical technology company founded with the ambitious mission of transforming global access…